Wird geladen...
Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is genetically variable, allowing it to adapt to various hosts including humans. Indeed, SARS-CoV-2 has accumulated around two mutations per genome each month. The first relevant event in this context was the occurrence of the mutant D...
Gespeichert in:
| Veröffentlicht in: | Viruses |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8234553/ https://ncbi.nlm.nih.gov/pubmed/34207378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13061171 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|